Export 2632 results:
Author Title [ Type(Desc)] Year
Journal Article
A. W. Burks, Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., Vickery, B. P., Liu, A. H., Henning, A. K., Lindblad, R., Dawson, P., Plaut, M., Sampson, H. A., and CoFAR), T. Consortium, Sublingual Immunotherapy for Peanut Allergy: Long-Term Follow-up of a Randomized Multicenter Trial, J Allergy Clin Immunol, 2015.
J. Robinson-Papp, Gelman, B., Grant, I., Singer, E., Gensler, G., Morgello, S., and Consortium, N. NeuroA. I. D. S., Substance Abuse Increases the Risk of Neuropathy in an HIV-Infected Cohort, Muscle & Nerve, vol. 45, pp. 471-476, 2012.
J. Robinson-Papp, Gelman, B. B., Grant, I., Singer, E., Gensler, G., and Morgello, S., Substance abuse increases the risk of neuropathy in an HIV-infected cohort., Muscle Nerve, vol. 45, no. 4, pp. 471-6, 2012.
J. McNeely, Wright, S., Matthews, A. G., Rotrosen, J., Shelley, D., Buchholz, M. P., and Curro, F. A., Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers., J Am Dent Assoc, vol. 144, no. 6, pp. 627-38, 2013.
J. McNeely, Wright, S., Matthews, A., Rotrosen, J., Shelley, D., Buchholz, M. P., and Curro, F. A., Substance-Use Screening and Interventions in Dental Practices: Survey of Practice-Based Research Network Dentists Regarding Current Practices, Policies and Barriers, J Am Dent Assoc, vol. 144, pp. 627-638, 2013.
W. L. McBee, Rankin, M. W., Clemons, T. E., and Group, A. - R. Eye Diseas, Substitution of a telephone battery for an in-clinic assessment of cognitive function: correlation analysis from the AREDS Cognitive Function Ancillary Study, 2004.
R. Lindblad, Quinnan, K., and Wood, D., A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group, Transfusion, vol. 53, p. Supplement AP34, 2013.
S. P. Lerner, Bajorin, D. F., Dinney, C. P., Efstathiou, J. A., Groshen, S., Hahn, N. M., Hansel, D., Kwiatkowski, D., O'Donnell, M., Rosenberg, J., Svatek, R., Abrams, J. S., Al-Ahmadie, H., Apolo, A. B., Bellmunt, J., Callahan, M., Cha, E. K., Drake, C., Jarow, J., Kamat, A., Kim, W., Knowles, M., Mann, B., Marchionni, L., McConkey, D., McShane, L., Ramirez, N., Sharabi, A., Sharpe, A. H., Solit, D., Tangen, C. M., Amiri, A. Tawab, Van Allen, E., West, P. J., Witjes, J. A., and Quale, D. Zipursky, Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer., Bladder Cancer, vol. 2, no. 2, pp. 165-202, 2016.
E. Y. Chew, Lindblad, A. S., and Clemons, T., Summary results and recommendations from the age-related eye disease study., Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
E. Chew, Lindblad, A., Clemons, T., and Group, A. - R. Eye Diseas, Summary Results and Recommendations from the Age-Related Eye Disease Study, Arch Ophthalmol, vol. 127, pp. 1678-1679, 2009.
T. S. T. O. P. - R. O. P. M. Group, Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes, Pediatrics, vol. 105, pp. 295-310, 2000.
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes., Pediatrics, vol. 105, no. 2, pp. 295-310, 2000.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S., Hanto, D., Light, J., Bartlett, S., Tzakis, A., Pearson, T., Barin, B., Roland, M., and Stock, P., Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients, Surgery, vol. 152, pp. 376-381, 2012.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S. S., Hanto, D. W., Light, J., Bartlett, S. T., Tzakis, A. G., Pearson, T. C., Barin, B., Roland, M. E., and Stock, P. G., Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients., Surgery, vol. 152, no. 3, pp. 376-81, 2012.
A. S. Lindblad, Nolph, K. D., Novak, J. W., and Friedman, E. A., A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy., J Diabet Complications, vol. 2, no. 4, pp. 227-32, 1988.
H. O. Douglass, Moertel, C. G., Mayer, R. J., Thomas, P. R., Lindblad, A. S., Mittleman, A., Stablein, D. M., and Bruckner, H. W., Survival after postoperative combination treatment of rectal cancer., N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
D. M. Stablein, Carter, W. H., and Wampler, G. L., Survival analysis of drug combinations using a hazards model with time-dependent covariates., Biometrics, vol. 36, no. 3, pp. 537-46, 1980.
M. E. Roland, Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., Olthoff, K., Simon, D., Hardy, W. D., Beatty, G., and Stock, P. G., Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls., AIDS, vol. 30, no. 3, pp. 435-44, 2016.
A. Girach, Aiello, L., Milton, R., Davis, M., Danis, R., Zhi, X., Sheetz, M., Vignati, L., and Group, P. K. C. - D. R. S. 2Study, Sustained Moderate Visual Loss as a Predictive End Point for Visual Loss in Non-Proliferative Diabetic Retinopathy, Eye (Lond), vol. 23, pp. 209-214, 2009.
A. Girach, Aiello, L. P., Milton, R. C., Davis, M. D., Danis, R. P., Zhi, X., Sheetz, M. J., and Vignati, L., Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy., Eye (Lond), vol. 23, no. 1, pp. 209-14, 2009.
M. Eydelman, Hilmantel, G., Tarver, M. E., Hofmeister, E. M., May, J., Hammel, K., Hays, R. D., and Ferris, F., Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies., JAMA Ophthalmol, vol. 135, no. 1, pp. 13-22, 2017.
I. Hand, Boron, M., and Van Veldhuisen, P., Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry, 2001.
M. Hudak, Chartrand, S., and Registry, S. Outcomes, Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry, J Perinatology, vol. 21, pp. 500-501, 2001.
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses., Vaccines (Basel), vol. 8, no. 1, 2019.
I. Tellez, Sabbaj, S., Peng, X., Mulligan, M. J., and AVEG], theN. I. H. A. I. D. S. V., T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and gp120 prime-boost vaccines, 1999.